Skip to main content

Xatmep News

Methotrexate Reduces Pain in Hand Osteoarthritis With Synovitis

MONDAY, Nov. 6, 2023 – For patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events,...

Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children

TUESDAY, Sept. 26, 2023 – For children and young people with severe atopic dermatitis (AD), ciclosporin (CyA) and methotrexate (MTX) are both effective over 36 weeks, according to a study published...

Dexamethasone Best for Persistent, Recurrent Uveitic Macular Edema

THURSDAY, June 22, 2023 – For patients with minimally active or inactive uveitis and persistent or recurrent uveitic macular edema (ME), dexamethasone is significantly better for treatment than...

FDA Approves Xatmep (methotrexate) Oral Solution

Denver, April 26, 2017 — Silvergate Pharmaceuticals, Inc. leaders in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Acute Lymphoblastic Leukemia

Xatmep patient information at Drugs.com